Golgi phosphoprotein 3 promotes the proliferation of gallbladder carcinoma cells via regulation of the NLRP3 inflammasome

Zhu,Zhencheng; Zhu,Qingzhou; Cai,Dongping; Chen,Liang; Xie,Weixuan; Bai,Yang; Luo,Kunlun

doi:10.3892/or.2021.8064

Golgi phosphoprotein 3 promotes the proliferation of gallbladder carcinoma cells via regulation of the NLRP3 inflammasome

Authors:
- Zhencheng Zhu
- Qingzhou Zhu
- Dongping Cai
- Liang Chen
- Weixuan Xie
- Yang Bai
- Kunlun Luo
View Affiliations

Affiliations: Anhui Medical University, Hefei, Anhui 230032, P.R. China, Department of Laboratory, The 904th Hospital of Joint Logistic Support Force of PLA, Wuxi, Jiangsu 214044, P.R. China, Department of Cardiology, The 904th Hospital of Joint Logistic Support Force of PLA, Wuxi, Jiangsu 214044, P.R. China, Department of Hepatobiliary Surgery, The 904th Hospital of Joint Logistic Support Force of PLA, Wuxi, Jiangsu 214044, P.R. China
Published online on: April 26, 2021 https://doi.org/10.3892/or.2021.8064
Article Number: 113
Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Golgi phosphoprotein 3 (GOLPH3) has been demonstrated to promote tumor progression in various gastrointestinal malignancies. However, its effects in gallbladder carcinoma (GBC) remain unknown. In the present study, the expression levels of GOLPH3 and nucleotide‑binding domain leucine‑rich repeat and pyrin domain containing receptor 3 (NLRP3) in human GBC tissues were detected by immunohistochemistry, and the clinical data and survival of these patients were analyzed. Next, whether GOLPH3 could affect tumor proliferation via regulation of the NLRP3 inflammasome was investigated in vitro. The results demonstrated that GOLPH3 could promote GBC cell proliferation, and that it regulated protein expression levels of NLRP3, as well as Caspase‑1 P10. Conversely, knockdown of NLRP3 reversed the effects of GOLPH3 overexpression on GBC cell proliferation. GOLPH3 and NLRP3 expression levels were found to be upregulated in GBC tissues and their expression was positively correlated. The expression of GOLPH3 and NLRP3 was associated with the expression of the proliferative marker Ki‑67 in tissues, and associated with poor survival, tumor stage, degree of differentiation, depth of invasion, carbohydrate antigen 19‑9 and C‑reactive protein levels in patients with GBC. In summary, these results indicate that GOLPH3 promotes GBC cell proliferation via a NLRP3/Caspase‑1 pathway. GOLPH3 and NLRP3 participate in the process of human GBC growth and may serve as a potential therapeutic targets.

View Figures

View References

1	Hundal R and Shaffer EA: Gallbladder cancer: Epidemiology and outcome. Clin Epidemiol. 6:99–109. 2014.PubMed/NCBI
2	Gamboa AC and Maithel SK: The landmark series: Gallbladder cancer. Ann Surg Oncol. 27:2846–2858. 2020. View Article : Google Scholar : PubMed/NCBI
3	Song X, Hu Y, Li Y, Shao R, Liu F and Liu Y: Overview of current targeted therapy in gallbladder cancer. Signal Transduct Target Ther. 5:2302020. View Article : Google Scholar : PubMed/NCBI
4	Goetze TO: Gallbladder carcinoma: Prognostic factors and therapeutic options. World J Gastroenterol. 21:12211–12217. 2015. View Article : Google Scholar : PubMed/NCBI
5	Kuna RS and Field SJ: GOLPH3: A Golgi phosphatidylinositol(4)phosphate effector that directs vesicle trafficking and drives cancer. J Lipid Res. 60:269–275. 2019. View Article : Google Scholar : PubMed/NCBI
6	Zhou X, Xue P, Yang M, Shi H, Lu D, Wang Z, Shi Q, Hu J, Xie S, Zhan W and Yu R: Protein kinase D2 promotes the proliferation of glioma cells by regulating Golgi phosphoprotein 3. Cancer Lett. 355:121–129. 2014. View Article : Google Scholar : PubMed/NCBI
7	Sechi S, Frappaolo A, Karimpour-Ghahnavieh A, Piergentili R and Giansanti MG: Oncogenic roles of GOLPH3 in the physiopathology of cancer. Int J Mol Sci. 21:9332020. View Article : Google Scholar : PubMed/NCBI
8	Farber-Katz SE, Dippold HC, Buschman MD, Peterman MC, Xing M, Noakes CJ, Tat J, Ng MM, Rahajeng J, Cowan DM, et al: DNA damage triggers Golgi dispersal via DNA-PK and GOLPH3. Cell. 156:413–427. 2014. View Article : Google Scholar : PubMed/NCBI
9	Buschman MD, Xing M and Field SJ: The GOLPH3 pathway regulates Golgi shape and function and is activated by DNA damage. Front Neurosci. 9:3622015. View Article : Google Scholar : PubMed/NCBI
10	Bergeron JJM, Au CE, Thomas DY and Hermo L: Proteomics identifies Golgi phosphoprotein 3 (GOLPH3) with a link between Golgi structure, cancer, DNA damage and protection from cell death. Mol Cell Proteomics. 16:2048–2054. 2017. View Article : Google Scholar : PubMed/NCBI
11	Tang S, Pan H, Wei W, Yang H, Liu J and Yang R: GOLPH3: A novel biomarker that correlates with poor survival and resistance to chemotherapy in breast cancer. Oncotarget. 8:105155–105169. 2017. View Article : Google Scholar : PubMed/NCBI
12	Liu H, Wang X, Feng B, Tang L, Li W, Zheng X, Liu Y, Peng Y, Zheng G and He Q: Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway. BMC Cancer. 18:6612018. View Article : Google Scholar : PubMed/NCBI
13	Liu J, Wei H, Lai L, Wang Y, Han X and Zhang Z: Golgi phosphoprotein-3 promotes invasiveness of gastric cancer cells through the mTOR signalling pathway. Clin Invest Med. 42:E38–E47. 2019. View Article : Google Scholar : PubMed/NCBI
14	Zhao C, Zhang J, Ma L, Wu H, Zhang H, Su J, Geng B, Yao Q and Zheng J: GOLPH3 promotes angiogenesis of lung adenocarcinoma by regulating the Wnt/β-catenin signaling pathway. Onco Targets Ther. 13:6265–6277. 2020. View Article : Google Scholar : PubMed/NCBI
15	Zhang Q, Zhuang J, Deng Y, Yang L, Cao W, Chen W, Lin T, Lv X, Yu H, Xue Y and Guo H: miR34a/GOLPH3 axis abrogates urothelial bladder cancer chemoresistance via reduced cancer stemness. Theranostics. 7:4777–4790. 2017. View Article : Google Scholar : PubMed/NCBI
16	Yu T, An Q, Cao XL, Yang H, Cui J, Li ZJ and Xiao G: GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K/AKT/mTOR pathway. Life Sci. 260:1182942020. View Article : Google Scholar : PubMed/NCBI
17	Zeng Z, Lin H, Zhao X, Liu G, Wang X, Xu R, Chen K, Li J and Song L: Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor. Clin Cancer Res. 18:4059–4069. 2012. View Article : Google Scholar : PubMed/NCBI
18	Lim Y and Kumar S: A single cut to pyroptosis. Oncotarget. 6:36926–36927. 2015. View Article : Google Scholar : PubMed/NCBI
19	Islam MT, Bardaweel SK, Mubarak MS, Koch W, Gaweł-Beben K, Antosiewicz B and Sharifi-Rad J: Immunomodulatory effects of diterpenes and their derivatives through NLRP3 inflammasome pathway: A review. Front Immunol. 11:5721362020. View Article : Google Scholar : PubMed/NCBI
20	Latz E, Xiao TS and Stutz A: Activation and regulation of the Inflammasomes. Nat Rev Immunol. 13:397–411. 2013. View Article : Google Scholar : PubMed/NCBI
21	Chen J and Chen ZJ: PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation. Nature. 564:71–76. 2018. View Article : Google Scholar : PubMed/NCBI
22	Feng YS, Tan ZX, Wu LY, Dong F and Zhang F: The involvement of NLRP3 inflammasome in the treatment of Alzheimer's disease. Ageing Res Rev. 64:1011922020. View Article : Google Scholar : PubMed/NCBI
23	Lu F, Zhao Y, Pang Y, Ji M, Sun Y, Wang H, Zou J, Wang Y, Li G, Sun T, et al: NLRP3 inflammasome upregulates PD-L1 expression and contriwhilees to immune suppression in lymphoma. Cancer Lett. 497:178–189. 2021. View Article : Google Scholar : PubMed/NCBI
24	Tezcan G, Garanina EE, Zhuravleva MN, Hamza S, Rizvanov AA and Khaiboullina SF: Rab GTPase mediating regulation of NALP3 in colorectal cancer. Molecules. 25:48342020. View Article : Google Scholar : PubMed/NCBI
25	Wang Y, Kong H, Zeng X, Liu W, Wang Z, Yan X, Wang H and Xie W: Activation of NLRP3 inflammasome enhances the proliferation and migration of A549 lung cancer cells. Oncol Rep. 35:2053–2064. 2016. View Article : Google Scholar : PubMed/NCBI
26	Chen Z, Liu Q, Zhu Z, Xiang F, Zhang M, Wu R and Kang X: Ursolic acid protects against proliferation and inflammatory response in LPS-Treated gastric tumour model and cells by inhibiting NLRP3 inflammasome activation. Cancer Manag Res. 12:8413–8424. 2020. View Article : Google Scholar : PubMed/NCBI
27	Chen Z, He M, Chen J, Li C and Zhang Q: Long non-coding RNA SNHG7 inhibits NLRP3-dependent pyroptosis by targeting the miR-34a/SIRT1 axis in liver cancer. Oncol Lett. 20:893–901. 2020. View Article : Google Scholar : PubMed/NCBI
28	Guo R, Qin Y, Shi P, Xie J, Chou M and Chen Y: IL-1β promotes proliferation and migration of gallbladder cancer cells via Twist activation. Oncol Lett. 12:4749–4755. 2016. View Article : Google Scholar : PubMed/NCBI
29	Dippold HC, Ng MM, Farber-Katz SE, Lee SK, Kerr ML, Peterman MC, Sim R, Wiharto PA, Galbraith KA, Madhavarapu S, et al: GOLPH3 bridges phosphatidylinositol-4-phosphate and actomyosin to stretch and shape the Golgi to promote budding. Cell. 139:337–351. 2009. View Article : Google Scholar : PubMed/NCBI
30	Li X, Zhang X, Pan Y, Shi G, Ren J, Fan H, Dou H and Hou Y: mTOR regulates NLRP3 inflammasome activation via reactive oxygen species in murine lupus. Acta Biochim Biophys Sin (Shanghai). 50:888–896. 2018. View Article : Google Scholar : PubMed/NCBI
31	Zhang Z, Meszaros G, He WT, Xu Y, de Fatima Magliarelli H, Mailly L, Mihlan M, Liu Y, Puig Gámez M, Goginashvili A, et al: Protein kinase D at the Golgi controls NLRP3 inflammasome activation. J Exp Med. 214:2671–2693. 2017. View Article : Google Scholar : PubMed/NCBI
32	Friedrichs K, Gluba S, Eidtmann H and Jonat W: Overexpression of p53 and prognosis in breast cancer. Cancer. 72:3641–3647. 1993. View Article : Google Scholar : PubMed/NCBI
33	Lamartina L, Grani G, Arvat E, Nervo A, Zatelli MC, Rossi R, Puxeddu E, Morelli S, Torlontano M, Massa M, et al: 8th edition of the AJCC/TNM staging system of thyroid cancer: What to expect (ITCO#2). Endocr Relat Cancer. 25:L7–L11. 2018. View Article : Google Scholar : PubMed/NCBI
34	Hui AM, Shi YZ, Li X, Sun L, Guido T, Takayama T and Makuuchi M: Proliferative marker Ki-67 in gallbladder carcinomas: High expression level predicts early recurrence after surgical resection. Cancer Lett. 176:191–198. 2002. View Article : Google Scholar : PubMed/NCBI